Table 2

Summary of studies included in qualitative synthesis

MeasureYear ValidatedStudy PopulationDiversity of Participant SampleNumber of ItemsRecall PeriodAge Range as provided in the studyNumber of Languages AvailableEase of Scoring*Time required to complete in minutes (number of items)
FSFI2012217 (female cancer survivors)Not provided194 wk18–501 (English)Simple math5–10 (19)
SABIS2009353 (breast cancer patients)89.5% Caucasian, 4.7% Native
American, 2.9% Black, 2%
Asian, 0.9% Hispanic
14Posttreatment§Average age of 49Simple math0–5 (14)
SABIS-G2011294 (gynecological cancer patients)81.6% Caucasian, 6.8% Asian,
3.4% Black, 8.2% Other
7Posttreatment27–801 (English)Statistical analysis0–5 (7)
EORTC QLQ CX-24200616712 different countries represented24Past weekAverage age of 48.6>12Simple math10–15 (24)
EORTC QLQ EN-24201028610 different countries represented24Past week; past 4 wk35.8–87.839Simple math10–15 (24)
SVQ2004257Denmark represented27Past month28–772 (Danish, English)Simple math10–15 (24)
GLQ2007198Not provided21 total
items; 11 items specific to sexual functioning
NoneNot provided2 (Dutch, English)Qualitative analysis and simple math0-5 (11)
InSYNC2015114 (56 breast cancer patients)Both men and women represented: 88% Caucasian
men, 93% Caucasian
women, 10 Black men, 5% Black women
12No time frame given18+1 (English)Qualitative analysis0-5 (12)
SEXSAT-Q2019148 (breast cancer patients)Not provided17No time frame given18–652 (English, Spanish)Simple math5–10 (17)
SAQ1996528Not provided22Past month35–651 (English)Qualitative analysis only10–15 (23)
MeasureYear ValidatedStudy PopulationDiversity of Participant SampleNumber of ItemsRecall PeriodAge Range as provided in the studyNumber of Languages AvailableEase of Scoring*Time required to complete in minutes (number of items)
FSFI2012217 (female cancer survivors)Not provided194 wk18–501 (English)Simple math5–10 (19)
SABIS2009353 (breast cancer patients)89.5% Caucasian, 4.7% Native
American, 2.9% Black, 2%
Asian, 0.9% Hispanic
14Posttreatment§Average age of 49Simple math0–5 (14)
SABIS-G2011294 (gynecological cancer patients)81.6% Caucasian, 6.8% Asian,
3.4% Black, 8.2% Other
7Posttreatment27–801 (English)Statistical analysis0–5 (7)
EORTC QLQ CX-24200616712 different countries represented24Past weekAverage age of 48.6>12Simple math10–15 (24)
EORTC QLQ EN-24201028610 different countries represented24Past week; past 4 wk35.8–87.839Simple math10–15 (24)
SVQ2004257Denmark represented27Past month28–772 (Danish, English)Simple math10–15 (24)
GLQ2007198Not provided21 total
items; 11 items specific to sexual functioning
NoneNot provided2 (Dutch, English)Qualitative analysis and simple math0-5 (11)
InSYNC2015114 (56 breast cancer patients)Both men and women represented: 88% Caucasian
men, 93% Caucasian
women, 10 Black men, 5% Black women
12No time frame given18+1 (English)Qualitative analysis0-5 (12)
SEXSAT-Q2019148 (breast cancer patients)Not provided17No time frame given18–652 (English, Spanish)Simple math5–10 (17)
SAQ1996528Not provided22Past month35–651 (English)Qualitative analysis only10–15 (23)

EORTC = European organization for research and treatment of cancer quality of life; FSFI = female sexual function index; GLQ = gynaecologic Leiden questionnaire; InSYNC = information on sexual health: your needs after cancer; SABIS = sexual adjustment and body image scale; SABIS-G = sexual adjustment and body image scale-gynecologic cancer; SAQ = sexual activity questionnaire; SEXSAT-Q = sexual satisfaction questionnaire; SVQ = sexual function and vaginal changes questionnaire.

Ease of scoring was assessed using 3 categories: statistical analysis required, simple math required, or qualitative analysis.

Also validated in 58 prostate cancer patients

Pilot study included 20, and reduction sample included 152 breast cancer patients

§

Recall bias is present

Table 2

Summary of studies included in qualitative synthesis

MeasureYear ValidatedStudy PopulationDiversity of Participant SampleNumber of ItemsRecall PeriodAge Range as provided in the studyNumber of Languages AvailableEase of Scoring*Time required to complete in minutes (number of items)
FSFI2012217 (female cancer survivors)Not provided194 wk18–501 (English)Simple math5–10 (19)
SABIS2009353 (breast cancer patients)89.5% Caucasian, 4.7% Native
American, 2.9% Black, 2%
Asian, 0.9% Hispanic
14Posttreatment§Average age of 49Simple math0–5 (14)
SABIS-G2011294 (gynecological cancer patients)81.6% Caucasian, 6.8% Asian,
3.4% Black, 8.2% Other
7Posttreatment27–801 (English)Statistical analysis0–5 (7)
EORTC QLQ CX-24200616712 different countries represented24Past weekAverage age of 48.6>12Simple math10–15 (24)
EORTC QLQ EN-24201028610 different countries represented24Past week; past 4 wk35.8–87.839Simple math10–15 (24)
SVQ2004257Denmark represented27Past month28–772 (Danish, English)Simple math10–15 (24)
GLQ2007198Not provided21 total
items; 11 items specific to sexual functioning
NoneNot provided2 (Dutch, English)Qualitative analysis and simple math0-5 (11)
InSYNC2015114 (56 breast cancer patients)Both men and women represented: 88% Caucasian
men, 93% Caucasian
women, 10 Black men, 5% Black women
12No time frame given18+1 (English)Qualitative analysis0-5 (12)
SEXSAT-Q2019148 (breast cancer patients)Not provided17No time frame given18–652 (English, Spanish)Simple math5–10 (17)
SAQ1996528Not provided22Past month35–651 (English)Qualitative analysis only10–15 (23)
MeasureYear ValidatedStudy PopulationDiversity of Participant SampleNumber of ItemsRecall PeriodAge Range as provided in the studyNumber of Languages AvailableEase of Scoring*Time required to complete in minutes (number of items)
FSFI2012217 (female cancer survivors)Not provided194 wk18–501 (English)Simple math5–10 (19)
SABIS2009353 (breast cancer patients)89.5% Caucasian, 4.7% Native
American, 2.9% Black, 2%
Asian, 0.9% Hispanic
14Posttreatment§Average age of 49Simple math0–5 (14)
SABIS-G2011294 (gynecological cancer patients)81.6% Caucasian, 6.8% Asian,
3.4% Black, 8.2% Other
7Posttreatment27–801 (English)Statistical analysis0–5 (7)
EORTC QLQ CX-24200616712 different countries represented24Past weekAverage age of 48.6>12Simple math10–15 (24)
EORTC QLQ EN-24201028610 different countries represented24Past week; past 4 wk35.8–87.839Simple math10–15 (24)
SVQ2004257Denmark represented27Past month28–772 (Danish, English)Simple math10–15 (24)
GLQ2007198Not provided21 total
items; 11 items specific to sexual functioning
NoneNot provided2 (Dutch, English)Qualitative analysis and simple math0-5 (11)
InSYNC2015114 (56 breast cancer patients)Both men and women represented: 88% Caucasian
men, 93% Caucasian
women, 10 Black men, 5% Black women
12No time frame given18+1 (English)Qualitative analysis0-5 (12)
SEXSAT-Q2019148 (breast cancer patients)Not provided17No time frame given18–652 (English, Spanish)Simple math5–10 (17)
SAQ1996528Not provided22Past month35–651 (English)Qualitative analysis only10–15 (23)

EORTC = European organization for research and treatment of cancer quality of life; FSFI = female sexual function index; GLQ = gynaecologic Leiden questionnaire; InSYNC = information on sexual health: your needs after cancer; SABIS = sexual adjustment and body image scale; SABIS-G = sexual adjustment and body image scale-gynecologic cancer; SAQ = sexual activity questionnaire; SEXSAT-Q = sexual satisfaction questionnaire; SVQ = sexual function and vaginal changes questionnaire.

Ease of scoring was assessed using 3 categories: statistical analysis required, simple math required, or qualitative analysis.

Also validated in 58 prostate cancer patients

Pilot study included 20, and reduction sample included 152 breast cancer patients

§

Recall bias is present

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close